Class Action Lawsuit Alert: Levi & Korsinsky Reminds Inspire Medical Systems, Inc. (INSP) Investors of January 5, 2026 Deadline

NEW YORK, NY / ACCESS Newswire / January 3, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Inspire Medical Systems, Inc. (NYSE:INSP) securities. If you suffered a loss on your Inspire Medical Systems, Inc. investment and would like

LRN IMPORTANT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Stride, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important January 12 Deadline in Securities Class Action – LRN

NEW YORK, NY / ACCESS Newswire / January 3, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Stride, Inc. (NYSE:LRN) between October 22, 2024 and October 28, 2025, both dates inclusive (the "Class Period"), of the important January 12, 2026 lead plaintiff deadline. SO WHAT: If

TLX FINAL DEADLINE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Telix Pharmaceuticals Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important January 9 Deadline in Securities Class Action First Filed by the Firm – TLX

NEW YORK, NY / ACCESS Newswire / January 3, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ:TLX) between February 21, 2025 and August 28, 2025, both dates inclusive (the "Class Period"), of the important January 9, 2026 lead plaintiff deadline in the

Press Ranger Named Best Public Relations (PR) Software for 2026 by Forbes

San Francisco, CA, Jan. 03, 2026 (GLOBE NEWSWIRE) — Press Ranger, an AI-driven public relations tool, has been honored as the Best Public Relations (PR) Software for 2026 by Forbes. This accolade highlights Press Ranger's commitment to revolutionizing the PR industry with cutting-edge technology that simplifies and enhances the process of media engagement. Forbes names

Scroll to Top